Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-22-028761

SVP, Chief Business Officer gave up 1,326 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Korbel Gregory Alan SVP, Chief Business Officer 2022-02-25 Shares withheld for taxes −1,326 $1.74 $2,307 15,841 D
Loading xslF345X03/tm227953-3_4seq1.xml…